Ultra-early Tranexamic Acid After Subarachnoid Hemorrhage.

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 955 participants.

Also called NCT02684812

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 955 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02684812
Other papers using this trial's data
  • Cost-Effectiveness of Ultra-Early Tranexamic Acid as Add-On to Standard Care After Subarachnoid Hemorrhage (ULTRA Trial) European journal of neurology, 2025-08 DOI, PubMed 40843772, PMC12371436 In the PMC Open Access subset under CC BY-NC.
  • Quality of life after tranexamic acid in subarachnoid hemorrhage: post-hoc analysis of the ULTRA trial Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2026-05-03 DOI, PubMed 42070193, PMC13136198 In the PMC Open Access subset under CC BY.
  • Tranexamic Acid After Aneurysmal Subarachnoid Hemorrhage: Post Hoc Analysis of the ULTRA Trial Neurology, 2022-12-05 DOI, PubMed 36266046
  • Tranexamic acid after aneurysmal subarachnoid hemorrhage is associated with worse outcome in males: post hoc analysis of the ULTRA trial Journal of neurology, 2026-08-19 DOI, PubMed 42616160, PMC13490208 In the PMC Open Access subset under CC BY.
  • Ultra-Early and Short-Term Tranexamic Acid Treatment in Patients With Good- and Poor-Grade Aneurysmal Subarachnoid Hemorrhage Neurology, 2024-06-25 DOI, PubMed 38788175, PMC11226311 In the PMC Open Access subset under CC BY-NC-ND.
  • Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial Lancet (London, England), 2021-01-09 DOI, PubMed 33357465

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02684812. Randomized; single masking; primary purpose treatment. Start 2012-07-16 (actual); primary completion 2019-07-29 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ultra-early Tranexamic Acid After Subarachnoid Hemorrhage.
Acronym
ULTRA
Condition
Subarachnoid Hemorrhage
Intervention (Drug)
Tranexamic Acid
Lead sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (class: other)
Collaborator
Stichting Nuts Ohra (class: other)

Record details

Record id
cardio:ct-nct02684812
Content hash
a882bfec62bb5f3a1e79a89359d183e5f71cc902803a175d075e8762c3e14a73